U.S. Markets closed

RedHill closes $20M public offering to prep commercialization of new drug

Seth Gulledge
RedHill closes $20M public offering to prep commercialization of new drug

RedHill Biopharma just closed on a $20 million public offering to fund the commercial launch of its drug, Talicia – which means expansion of the company's Raleigh team.